Stay updated on Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page now shows a 403 Forbidden error page, replacing the study record content with an error screen. Navigation and related study details are no longer visible.SummaryDifference21%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision metadata on the page shows a new version, v3.6.6, has been published to replace the prior v3.6.5. This indicates a minor update to the page rather than a change to the study details.SummaryDifference0.0%

- Check35 days agoChange DetectedA funding note indicating NIH grant/contract support in 2015 was added to the study record, documenting the source of funding.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing Revision: v3.6.4, indicating a version update at the site level. This change does not modify the study details or other user-facing content on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a newer version of the page/document in the system.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page revision was updated to v3.6.3, representing a new version of the page content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.